Beautiful Plume vs

Amblyptilia acanthadactyla compared with Sphingomonas pseudosanguinis

Key Differences

Beautiful Plume is Least Concern while is Not Evaluated.

Taxonomic Classification

Rank	Beautiful Plume
Kingdom	Animalia (Animals)	Bacteria (Bacteria)
Phylum	Arthropoda (Arthropods)	Proteobacteria (Proteobacteria)
Class	Insecta (Insects)	Alphaproteobacteria (Alphaproteobacteria)
Order	Lepidoptera (Butterflies & Moths)	Sphingomonadales (Sphingomonadales)
Family	Pterophoridae	Sphingomonadaceae
Genus	Amblyptilia	Sphingomonas
Species	Amblyptilia acanthadactyla	Sphingomonas pseudosanguinis

Conservation Status

Beautiful Plume

LC — Least Concern

NE — Not Evaluated

Physical Characteristics

Attribute	Beautiful Plume
Diet	—	—
Average Lifespan	—	—
Average Length	—	—
Average Weight	—	—

Habitat & Geographic Range

Beautiful Plume

Habitat

Found across multiple habitat types including temperate coniferous forests, montane grasslands and shrublands, and Mediterranean forests and woodlands, among 4 distinct biome types within the Palearctic biogeographic realm. Populations are also found in montane and highland environments at higher elevations.

Range

Widely distributed across Africa (Morocco), Asia (4 countries), and Europe (31 countries).

Habitat

Native to Asia, inhabiting ecosystems characteristic of the region.

Range

Found in Taiwan.

Beautiful Plume

The Beautiful Plume (Amblyptilia acanthadactyla) is a species in the genus Amblyptilia. It is currently classified as Least Concern on the IUCN Red List. Found across multiple habitat types including temperate coniferous forests, montane grasslands and shrublands, and Mediterranean forests and woodlands, among 4 distinct biome types within the Palearctic biogeographic realm. Populations are.

Sphingomonas pseudosanguinis is a Gram-negative aerobic rod resembling but distinct from blood-associated sphingomonads. It has been isolated from hospital environments, clinical specimens, and diverse soils. This aerobic chemoheterotroph is occasionally an opportunistic pathogen in immunocompromised patients.